Literature DB >> 26852244

Individualized radiotherapy by combining high-end irradiation and magnetic resonance imaging.

Stephanie E Combs1,2, Fridtjof Nüsslin3, Jan J Wilkens3,4.   

Abstract

Image-guided radiotherapy (IGRT) has been integrated into daily clinical routine and can today be considered the standard especially with high-dose radiotherapy. Currently imaging is based on MV- or kV-CT, which has clear limitations especially in soft-tissue contrast. Thus, combination of magnetic resonance (MR) imaging and high-end radiotherapy opens a new horizon. The intricate technical properties of MR imagers pose a challenge to technology when combined with radiation technology. Several solutions that are almost ready for routine clinical application have been developed. The clinical questions include dose-escalation strategies, monitoring of changes during treatment as well as imaging without additional radiation exposure during treatment.

Keywords:  Image-guided radiotherapy; Individualized medicine; Magnetic resonance-guided radiotherapy; Organ sparing treatments; Organs at risk

Mesh：

Year:  2016        PMID： 26852244     DOI： 10.1007/s00066-016-0944-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


  60 in total

1.  Dose optimization for the MRI-accelerator: IMRT in the presence of a magnetic field.

Authors:  A J E Raaijmakers; B Hårdemark; B W Raaymakers; C P J Raaijmakers; J J W Lagendijk
Journal:  Phys Med Biol       Date:  2007-11-15       Impact factor: 3.609

2.  MRI/linac integration.

Authors:  Jan J W Lagendijk; Bas W Raaymakers; Alexander J E Raaijmakers; Johan Overweg; Kevin J Brown; Ellen M Kerkhof; Richard W van der Put; Björn Hårdemark; Marco van Vulpen; Uulke A van der Heide
Journal:  Radiother Oncol       Date:  2007-11-26       Impact factor: 6.280

3.  Image guided personalization of reaction-diffusion type tumor growth models using modified anisotropic eikonal equations.

Authors:  Ender Konukoglu; Olivier Clatz; Bjoern H Menze; Bram Stieltjes; Marc-André Weber; Emmanuel Mandonnet; Hervé Delingette; Nicholas Ayache
Journal:  IEEE Trans Med Imaging       Date:  2009-07-14       Impact factor: 10.048

Review 4.  Motion in radiotherapy: particle therapy.

Authors:  C Bert; M Durante
Journal:  Phys Med Biol       Date:  2011-07-20       Impact factor: 3.609

5.  The rotating biplanar linac-magnetic resonance imaging system.

Authors:  Biagio Gino Fallone
Journal:  Semin Radiat Oncol       Date:  2014-07       Impact factor: 5.934

Review 6.  Pelvic MRI for guiding treatment decisions in rectal cancer.

Authors:  Robert Glynne-Jones; David Tan; Vicky Goh
Journal:  Oncology (Williston Park)       Date:  2014-08       Impact factor: 2.990

7.  A dual model HU conversion from MRI intensity values within and outside of bone segment for MRI-based radiotherapy treatment planning of prostate cancer.

Authors:  Juha Korhonen; Mika Kapanen; Jani Keyriläinen; Tiina Seppälä; Mikko Tenhunen
Journal:  Med Phys       Date:  2014-01       Impact factor: 4.071

8.  The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer.

Authors:  Wouter van Elmpt; Dirk De Ruysscher; Anke van der Salm; Annemarie Lakeman; Judith van der Stoep; Daisy Emans; Eugène Damen; Michel Öllers; Jan-Jakob Sonke; José Belderbos
Journal:  Radiother Oncol       Date:  2012-04-06       Impact factor: 6.280

9.  Outcome after neoadjuvant chemoradiation and correlation with nutritional status in patients with locally advanced pancreatic cancer.

Authors:  P Naumann; D Habermehl; T Welzel; J Debus; S E Combs
Journal:  Strahlenther Onkol       Date:  2013-07-31       Impact factor: 3.621

10.  Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer.

Authors:  Samantha Warren; Mike Partridge; Rhys Carrington; Chris Hurt; Thomas Crosby; Maria A Hawkins
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-10-01       Impact factor: 7.038
View more
  8 in total

1.  Long-term survival following additive radiotherapy in patients with atypical teratoid rhabdoid tumors.

Authors:  Khaled Elsayad; Jan Kriz; Laith Samhouri; Uwe Haverkamp; Ronald Straeter; Walter Stummer; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2016-06-07       Impact factor: 3.621

Review 2.  "Radio-oncomics" : The potential of radiomics in radiation oncology.

Authors:  Jan Caspar Peeken; Fridtjof Nüsslin; Stephanie E Combs
Journal:  Strahlenther Onkol       Date:  2017-07-07       Impact factor: 3.621

Review 3.  The future of image-guided radiotherapy will be MR guided.

Authors:  Julianne M Pollard; Zhifei Wen; Ramaswamy Sadagopan; Jihong Wang; Geoffrey S Ibbott
Journal:  Br J Radiol       Date:  2017-03-29       Impact factor: 3.039

4.  [The selective waiving of neoadjuvant (chemo)radiotherapy for rectal cancer lacks evidence].

Authors:  D Habermehl
Journal:  Chirurg       Date:  2016-10       Impact factor: 0.955

5.  Voxel-wise correlation of functional imaging parameters in HNSCC patients receiving PET/MRI in an irradiation setup.

Authors:  Kerstin Zwirner; Daniela Thorwarth; René M Winter; Stefan Welz; Jakob Weiss; Nina F Schwenzer; Holger Schmidt; Christian la Fougère; Konstantin Nikolaou; Daniel Zips; Sergios Gatidis
Journal:  Strahlenther Onkol       Date:  2018-03-21       Impact factor: 3.621

6.  MR-CBCT image-guided system for radiotherapy of orthotopic rat prostate tumors.

Authors:  Tsuicheng D Chiu; Tatsuya J Arai; James Campbell Iii; Steve B Jiang; Ralph P Mason; Strahinja Stojadinovic
Journal:  PLoS One       Date:  2018-05-30       Impact factor: 3.240

Review 7.  Potentials and challenges of diffusion-weighted magnetic resonance imaging in radiotherapy.

Authors:  Sara Leibfarth; René M Winter; Heidi Lyng; Daniel Zips; Daniela Thorwarth
Journal:  Clin Transl Radiat Oncol       Date:  2018-09-20

8.  Recurrence pattern analysis after [68Ga]-DOTATATE-PET/CT -planned radiotherapy of high-grade meningiomas.

Authors:  Barbara Zollner; Ute Ganswindt; Cornelius Maihöfer; Stefanie Corradini; Nathalie Lisa Albert; Christian Schichor; Claus Belka; Maximilian Niyazi
Journal:  Radiat Oncol       Date:  2018-06-14       Impact factor: 3.481
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.